What are the administration guidelines for Sermorelin (Growth Hormone-Releasing Hormone) glycine troche?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Administration Guidelines for Sermorelin Glycine Troche

Sermorelin glycine troches should be placed under the tongue and allowed to dissolve completely, typically administered once daily at bedtime.

What is Sermorelin?

Sermorelin is a 29-amino acid analogue of human growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to produce and release growth hormone. It is the shortest synthetic peptide that maintains the full biological activity of natural GHRH 1.

Administration Instructions

Proper Troche Administration Technique:

  • Place the troche under the tongue (sublingual administration)
  • Allow it to dissolve completely
  • Do not swallow the troche whole
  • Do not eat, drink, or smoke while the troche is dissolving
  • Avoid swallowing saliva until the troche has completely dissolved

Timing and Dosage:

  • Administer once daily
  • Best taken at bedtime to mimic natural growth hormone release patterns
  • Standard dosage is typically 30 μg/kg bodyweight 1

Clinical Considerations

Expected Effects:

  • Stimulates endogenous growth hormone secretion from the anterior pituitary
  • Effects may take several months to become noticeable
  • Regular monitoring of response is recommended

Duration of Treatment:

  • Long-term effects on adult height and other outcomes require continued monitoring
  • Limited data suggest effects can be maintained for up to 36 months of continued treatment 1

Common Side Effects

  • Transient facial flushing
  • Pain or irritation at administration site (in this case, under the tongue)
  • These side effects are typically mild and transient 1

Important Precautions

  • Sermorelin is not recommended as first-line therapy for growth hormone deficiency, as direct growth hormone therapy has shown superior results in comparative studies 2
  • The effect on final adult height is not yet determined with long-term treatment 1
  • Sermorelin does not cross the placenta, which is an important consideration for pregnant women 3

Monitoring

  • No specific routine monitoring tests are required for the medication itself
  • Clinical response should be evaluated periodically
  • For patients using sermorelin for growth hormone deficiency, height velocity should be monitored

Storage Instructions

  • Keep troches in their original container
  • Store at room temperature away from moisture and heat
  • Keep out of reach of children

By following these administration guidelines, patients can maximize the potential benefits of sermorelin glycine troches while minimizing potential side effects.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.